KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Assets Average (2016 - 2025)

Abbott Laboratories' Assets Average history spans 17 years, with the latest figure at $81.4 billion for Q1 2025.

  • For Q1 2025, Assets Average rose 11.79% year-over-year to $81.4 billion; the TTM value through Mar 2025 reached $81.4 billion, up 11.79%, while the annual FY2024 figure was $77.3 billion, 90.43% up from the prior year.
  • Assets Average for Q1 2025 was $81.4 billion at Abbott Laboratories, up from $77.9 billion in the prior quarter.
  • Across five years, Assets Average topped out at $81.4 billion in Q1 2025 and bottomed at $40.4 billion in Q4 2022.
  • The 5-year median for Assets Average is $72.8 billion (2024), against an average of $64.8 billion.
  • The largest annual shift saw Assets Average decreased 13.3% in 2022 before it surged 79.86% in 2023.
  • A 5-year view of Assets Average shows it stood at $40.5 billion in 2021, then fell by 0.33% to $40.4 billion in 2022, then soared by 79.86% to $72.7 billion in 2023, then rose by 7.2% to $77.9 billion in 2024, then increased by 4.55% to $81.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Assets Average are $81.4 billion (Q1 2025), $77.9 billion (Q4 2024), and $73.7 billion (Q3 2024).